Apyx Medical Corp
APYX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000719135
No open-market purchases or sales by Apyx Medical Corp insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $110.7M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Apyx Medical Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Apyx Medical Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Waldman Lawrence | Director | 12,314Indirect | Jul 2, 2026 | 2 |
| Roman Shawn David | Chief Operating Officer | 16,467Indirect | Jun 17, 2026 | 3 |
| Hill Matthew C | Chief Financial Officer | 8,500 | Jun 15, 2026 | 1 |
| Citronowicz Moshe | Sr. V.P. of Operations | 493,504 | Jun 15, 2026 | 2 |
| Vizirgianakis Stavros G. | Director | 2,196,191 | Jun 15, 2026 | 1 |
| Goodwin Charles D. II | Chief Executive Officer | 90,000 | Jun 15, 2026 | 1 |
| Baylor-Henry Minnie | Director | – | Jun 15, 2026 | 1 |
| Levine Wendy Lauren | Director | – | Jun 15, 2026 | 1 |
| Geraghty Michael | Director | 27,500 | Aug 12, 2024 | 0 |
| Andres John C. | Director | – | Aug 12, 2024 | 0 |
| Swandal Craig A. | Director | 60,173 | Aug 12, 2024 | 0 |
| Hornsby Todd | Executive Vice President | 0 | Jan 11, 2024 | 0 |
| Makrides Andrew | Director | 624,389 | Aug 15, 2023 | 0 |
| Semb Tara | Chief Financial Officer | – | Jan 13, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 (view filing) | Aug 13, 2024 | 202 days | Hill Matthew CChief Financial Officer | PPurchase | +6.00K | $1.13 | +$6.78K | +240.0%8.50K after | Amended |
| Dec 14, 2023 (view filing) | Dec 12 | 2 days | Hill Matthew CChief Financial Officer | PPurchase | +2.50K | $2.19 | +$5.47K | New position2.50K after | |
| Nov 15, 2023 (view filing) | Nov 14 | 1 day | Goodwin Charles D. IIChief Executive Officer | PPurchase | +50.0K | $1.57 | +$78.5K | +125.0%90.0K after | |
| Jun 29, 2023 (view filing) | Jun 26 | 3 days | Hornsby ToddExecutive Vice President | SSale | −15.0K | $7.56 | −$113.4K | −100.0%0 after | Amended10b5-1 |
| Aug 31, 2022 (view filing) | Aug 29 | 2 days | Goodwin Charles D. IIChief Executive Officer | PPurchase | +11.8K | $5.96 | +$70.1K | +41.6%40.0K after | 2 lots |